Folate and Vitamin E Deficiency Impair Cognitive Performance in Mice Subjected to Oxidative Stress: Differential Impact on Normal Mice and Mice Lacking Apolipoprotein E

NeuroMolecular Medicine

Volumn 4, Issue 3, 2003, Pages 197-201

  Mihalick, Shelia M ^a   Ortiz, Daniela ^a   Kumar, Ramya ^a   Rogers, Eugene ^a   Shea, Thomas B ^a  

^a University of Massachusetts Lowell   (United States)

Author keywords

Apolipoprotein E; Cognition; Folate; Iron; Neurodegeneration; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; FOLIC ACID;

AGE; ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FOLIC ACID DEFICIENCY; GENETIC PREDISPOSITION; HEREDITY; INJURY; MAZE TEST; MOUSE; NERVE DEGENERATION; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGING; ANIMALS; APOLIPOPROTEINS E; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FOLIC ACID; FOLIC ACID DEFICIENCY; GENETIC PREDISPOSITION TO DISEASE; MAZE LEARNING; MICE; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; VITAMIN E; VITAMIN E DEFICIENCY;

ANIMALIA;

EID: 0346098195     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:4:3:197     Document Type: Article

References (31)

1. Berr C. (2002) Oxidative stress and cognitive impairment in the elderly. J. Nutr. Health Aging 6, 261-266.
2. Butterfield D. A. and Lauderback C. M. (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease: potential causes and consequences involving amyloid-beta peptide-associated free radical oxidative stress. Free Rad. Biol. Med. 32, 1050-1060.
3. Corcoran K. A., Lu Y., Turner R.S., and Maren S. (2002) Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learn. Mem. 9, 243-252.
4. 12 excess on memory functioning in young chicks. Pharmacol. Biochem. Behav. 56, 189-197.
5. Floyd R. A. and Hensley K. (2002) Oxidative stress in brain aging. implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795-807.
6. Growdon J. (2001) Incorporating biomarkers into clinical drug trials in Alzheimer's disease. J. Alz. Dis. 3, 287-292.
7. Huang G. S., Yang S. M., Hong M. Y., Yang P. C., and Liu Y. C. (2000) Differential gene expression of livers from ApoE deficient mice. Life Sci. 68, 19-28.
8. Ho P.I., Collins S. C., Dhitavat S, et al. (2001) Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J. Neurochem. 78, 249-253.
9. Ho P.I., Ortiz D., Rogers E., and Shea T. B. (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70, 694-702.
10. Ho P., Ashline D., Dhitavat S. et al. (2003) Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol. Dis. 1, 32-42.
11. King D. L., Arendash G. W., Crawford F., Sterk T., Menendez J., Mullan M. J. (1999) Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 103, 145-162
12. Kruman II, Culmsee C., Chan S. L., et al. (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926
13. Kruman II, Kumaravel T. S., Lohani A. et al. (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of alzheimer's disease. J. Neurosci. 22, 1752-1762.
14. Lalonde R. (2002). The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26, 91-104.
15. 12 and folate levels on episodic memory functioning: a population-based study of healthy very old adults. Biol. Psychiatry 45, 1472-1480.
16. Mattson M. M. and Shea T.B. (2002) Folate and homocysteine in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137-146.
17. 6 and folate intake in AD and healthy aging. J. Nutr. Health Aging 3, 160-165.
18. Perry G., Cash A. D., Smith M. A. (2002a) Alzheimer disease and oxidative stress. J. Biomed. Biotechnol. 2, 120-123.
19. Perry G., Nunomura A., Hirai K., et al. (2002b) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 33, 1475-1479.
20. Postiglione A., Milan G., Ruocco A., et al. (2001)Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5, 10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia: a case-control study. Gerontology 6, 324-329.
21. Ramassamy C., Averill D., Beffert L., et al. (1999) Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic. Biol. Med. 27, 544-553.
22. Ramassamy C., Krzywkowski P., Averill D., et al. (2002) Impact of apolipoprotein E deficiency on oxidative insults and antioxidant levels in the brain. Mol. Brain Res. 86, 76-83
23. Rebeck G. W., Kindy M., and LaDu M. J. (2002) Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J. Alz. Dis. 4, 145-154.
24. Shea T. B. and Rogers E. (2002a) Homocysteine as a risk factor for Alzheimer's disease. New Eng. J. Med. 346, 2007.
25. Shea T. B. and Rogers E. (2002b) Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E. Mol. Brain Res. 108, 1-6.
26. Shea T. B., Lyons-Wieler J., and Rogers E. (2002a) Homocysteine, folate deprivation and Alzheimer's disease. J. Alz. Dis. 4, 261-268
27. Shea T. B., Rogers E., Ortiz D., and Sheu M. S. (2002b) Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Rad. Biol. Med. 33, 1115-1120.
28. Shea T. B., Rogers E., Ashline D., et al. (2002c) Vitamin E deficiency does not induce compensatory antioxidant increases in central nervous system tissue of apolipoprotein E-deficient mice. J. Alz. Dis. 4, 1-6.
29. Reyes-Engel A., Munoz E., Gaitan M. J., et al. (2002) Implications on human fertility of the 677C delta T and 1298A delta C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol. Hum. Reprod. 8, 952-957.
30. Veinbergs I., Mallory M., Sagara Y., and Masliah E. (2000) Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur. J. Neurosci. 12, 4541-4546
31. White A. R., Huang X., Jobling M. F., et al. (2001) Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J. Neurochem. 76, 1509-1520.